Morgan Stanley Maintains Overweight on S&P Global, Lowers Price Target to $398
Morgan Stanley analyst Toni Kaplan maintains S&P Global (NYSE:SPGI) with a Overweight and lowers the price target from $401 to $398.
Morgan Stanley Maintains Equal-Weight on Moody’s, Lowers Price Target to $298
Morgan Stanley analyst Toni Kaplan maintains Moody's (NYSE:MCO) with a Equal-Weight and lowers the price target from $305 to $298.
Morgan Stanley Maintains Underweight on Macerich, Lowers Price Target to $8.5
Morgan Stanley analyst Richard Hill maintains Macerich (NYSE:MAC) with a Underweight and lowers the price target from $11.25 to $8.5.
Citigroup Maintains Buy on Outfront Media, Lowers Price Target to $28
Citigroup analyst Jason Bazinet maintains Outfront Media (NYSE:OUT) with a Buy and lowers the price target from $30 to $28.
BTIG Maintains Buy on CytomX Therapeutics, Lowers Price Target to $8
BTIG analyst Kaveri Pohlman maintains CytomX Therapeutics (NASDAQ:CTMX) with a Buy and lowers the price target from $16 to $8.
Raymond James Downgrades SmartFinancial to Outperform, Lowers Price Target to $27
Raymond James analyst William Wallace downgrades SmartFinancial (NASDAQ:SMBK) from Strong Buy to Outperform and lowers the price target from $33 to $27.
Raymond James Maintains Outperform on Univest Financial, Lowers Price Target to $29
Raymond James analyst William Wallace maintains Univest Financial (NASDAQ:UVSP) with a Outperform and lowers the price target from $31 to $29.
Roth Capital Initiates Coverage On Kalera with Buy Rating, Announces Price Target of $6
Roth Capital analyst Brian White initiates coverage on Kalera (NASDAQ:KAL) with a Buy rating and announces Price Target of $6.
Keybanc Maintains Overweight on Welltower OP, Lowers Price Target to $95
Keybanc analyst Josh Beck maintains Welltower OP (NYSE:WELL) with a Overweight and lowers the price target from $98 to $95.
Citigroup Maintains Buy on Interpublic Gr of Cos, Lowers Price Target to $33
Citigroup analyst Jason Bazinet maintains Interpublic Gr of Cos (NYSE:IPG) with a Buy and lowers the price target from $43 to $33.